Loading, please wait ...

News Analytics

Qulipta jpg?VersionId=IgLO33WeIF31seP37wjQ7qrLctTmOAbr.
The race for supremacy is officially on among oral CGRP inhibitors to prevent migraine. Tuesday, AbbVie said the FDA has green-lighted its Qulipta, or atogepant, for prevention of episodic migraine.

The Angle

Subject Matter

  • Healthcare 75.36%
    • Hospitals, doctors and medical care 100.00%
  • Business, economics, society 24.64%
    • Society and people 100.00%

Emotional Reaction






Dimensions/Depth Chart

If you find a dimension intereseting, we recommend you pick up one or two facts that you find intriguing and place them into your memory. That way you will have 2nd degree information about the topic if it comes up in conversation.

Accordingly, you can do the same with others as well.